BL PharmTech

BL PharmTech Interest Coverage

The Interest Coverage Ratio of BL PharmTech (065170.KQ) as of Oct 24, 2026 is -2.15. In the previous year, Interest Coverage Ratio was -1.65 — a change of 30.42% (lower).

Interest Coverage

-2.15

YoY

30.42%

Last updated:

Interest Coverage Ratio of BL PharmTech is 2024 -2.15 . Interest Coverage Ratio of BL PharmTech was 2023 -1.65 . It decreases by 30.42% lower compared to the previous year.

The BL PharmTech Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
1.30 KRW
Jan 1, 2018
1.87 KRW
Jan 1, 2019
-61.15 KRW
Jan 1, 2020
-3.20 KRW
Jan 1, 2021
-0.84 KRW
Jan 1, 2022
-1.85 KRW
Jan 1, 2023
-1.65 KRW
Jan 1, 2024
-2.15 KRW
The BL PharmTech Interest Coverage history
YEARInterest CoverageYoY
-2.15+30.42%
-1.65-10.90%
-1.85+119.21%
-0.84-73.59%
-3.20-94.77%
-61.15-3,364.30%
1.87+44.17%
1.30+124.73%
0.58-252.93%
-0.38-131.52%
1.20—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BL PharmTech Stock analysis

What does BL PharmTech do? BL PharmTech Corp generates revenue through four business segments. The Health Functional Food Business segment sells red ginsengs, diet foods, and vitamins. The Cosmetics Business segment offers anti-aging skincare products. The Diagnostic and Medical Business segment provides diagnostic kits and related products. The Other segment distributes health foods and other products. Customers include consumers seeking health supplements, skincare solutions, and medical diagnostic tools. The company targets health-conscious individuals and medical professionals who purchase these specialized products. The firm's revenue streams are derived from direct sales of manufactured goods across all segments. Red ginsengs, diet foods, and vitamins are sold under the Health Functional Food Business segment. Anti-aging skincare products come from the Cosmetics Business segment. Diagnostic kits and other medical products are sold through the Diagnostic and Medical Business segment. Distribution services for health foods form the Other segment's contribution to revenue. BL PharmTech Corp's customers primarily consist of end consumers for health functional foods and cosmetics, while medical institutions purchase diagnostic kits. The company's products are distributed through retail channels and direct sales to healthcare providers. Revenue is generated from the sale of manufactured items rather than licensing or subscription models. BL PharmTech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BL PharmTech stock

Interest Coverage Ratio of BL PharmTech is -2.15 in 2024.

Interest Coverage Ratio of BL PharmTech changed from -1.65 to -2.15, representing a 30.42% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio BL PharmTech since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's BL PharmTech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — BL PharmTech

All Key Metrics — BL PharmTech